A Phase 1 Study Investigating the Safety, Tolerability and Pharmacokinetics of KNX100 in Healthy Volunteers

NCT04901078 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

57

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteer Study
Opioid-use Disorder

Interventions

DRUG: KNX100

Sponsor

Kinoxis Therapeutics Pty Ltd

Collaborators

[object Object]